American vaccine development company Novavax announced on Monday that it would raise fresh capital through a $200 million preferred stock offering. The move is to help the company rush to develop a vaccine for the new coronavirus. Shares of Novavax were up 10.5% on the news. The private placement to investment fund RA Capital Management … Continue reading “Novavax to Raise Capital through $200M Stock Offering to Fund COVID-19 Vaccine”
Tag: nvax
Biotech & Pharma
Novavax Initiates Development of Vaccine for Wuhan Coronavirus
Novavax, a clinical-stage vaccine company headquartered in Gaithersburg, Maryland, saw its shares explode 60% in…
January 23, 2020